Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Rebecca Miksad

GI Oncology · BMC

View

Dr. Colin Weekes

GI Oncology · MGH

View

Dr. Elizabeth Jaffee

GI Oncology · Johns Hopkins

View

Dr. Aparna Parikh

GI Oncology · PHS

View

Dr. Laura Vater

GI Oncology · IUSM

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    EBDr. Erkut Borazanci

    Dr. Erkut Borazanci

    Medical Oncology · Gastrointestinal Oncology
    Honorhealth Research Institute
    erkut

    Research

    Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced-Mutated Metastatic Pancreatic Cancer

    2026

    Via Journal of Immunotherapy and Precision Oncology

    Research

    A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancreatic cancer

    2026

    Via Cancer

    Research

    Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction

    2025

    Via The Oncologist

    Research

    Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study

    2025

    Via Frontiers in Oncology

    Research

    Retrospective analysis of capecitabine maintenance therapy in pancreatic ductal adenocarcinoma

    2025

    Via Therapeutic Advances in Medical Oncology

    Research

    Adult pancreatoblastoma: Systematic review of the literature and case report of a young adult patient

    2025

    Via World Journal of Gastrointestinal Oncology

    Research

    Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma

    2025

    Via British Journal of Cancer

    Research

    Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

    2025

    Via Current Oncology

    Research

    Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer

    2025

    Via Redox Biology

    Research

    Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods

    2025

    Via NPJ Precision Oncology

    Research

    Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma

    2025

    Via Gastroenterology

    Research

    First-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity

    2024

    Via The Oncologist

    Research

    Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer

    2024

    Via Cancers

    Research

    Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study

    2024

    Via The Oncologist

    Research

    Hand therapy interventions for the prevention of chemotherapy-induced peripheral neuropathy of the hands in patients with pancreatic cancer

    2024

    Via The Oncologist